Christine Van Laer, PharmD

Center for Molecular and Vascular Biology, University of Leuven; Clinical Department of Laboratory Medicine, University Hospitals Leuven, Belgium

Christine Van Laer, PharmD, Clinical Department of Laboratory medicine, University Hospitals Leuven and Center for Molecular and Vascular Biology (CMVB), Deparment of Cardiovascular Sciences, University of Leuven, Belgium

Christine graduated as pharmacist at KULeuven in 2009. Thereafter she specialized in laboratory medicine until 2014 with a specific interest in laboratory hematology and hemostasis. She works as clinical biologist at the hematology and coagulation department of the clinical laboratories of the University Hospitals Leuven. In September 2019 she joined the CMVB laboratory to study the clinically relevance of novel genetic variants related to thrombosis and hemostasis.

Presentation(s):

• PB0666 - A new FVIII chromogenic assay with bovine FX is sensitive enough for the diagnosis of severe haemophilia A.

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• SSC 23.10 - Position of Next Generation Sequencing (NGS) Testing in the Diagnostic Algorithm of Inherited Thrombophilia

  Tuesday, July 12, 2022
  5:55 PM – 6:05 PM

• PB1111 - A novel prothrombin R533Q variant in patient with recurrent venous thrombosis

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM